Matches in DBpedia 2016-04 for { ?s ?p "Iprindole (Prondol, Galatur, Tertran), formerly known as pramindole, is a tricyclic antidepressant (TCA) used in Europe for the treatment of depression. It was introduced by Wyeth and has been used clinically since 1967. Notably, iprindole was the first second-generation antidepressant to be launched.Iprindole is unique compared to most other TCAs in that it is a relatively weak inhibitor of the reuptake of serotonin and norepinephrine and instead acts predominantly as an antagonist of 5-HT2 receptors, hence its classification as 'second-generation'. Additionally, side effects of iprindole are much less prominent relative to other TCAs and it is well tolerated. However, iprindole's efficacy may not be as great as other TCAs, especially in regards to anxiety relief."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Iprindole abstract "Iprindole (Prondol, Galatur, Tertran), formerly known as pramindole, is a tricyclic antidepressant (TCA) used in Europe for the treatment of depression. It was introduced by Wyeth and has been used clinically since 1967. Notably, iprindole was the first second-generation antidepressant to be launched.Iprindole is unique compared to most other TCAs in that it is a relatively weak inhibitor of the reuptake of serotonin and norepinephrine and instead acts predominantly as an antagonist of 5-HT2 receptors, hence its classification as 'second-generation'. Additionally, side effects of iprindole are much less prominent relative to other TCAs and it is well tolerated. However, iprindole's efficacy may not be as great as other TCAs, especially in regards to anxiety relief.".
- Q904673 abstract "Iprindole (Prondol, Galatur, Tertran), formerly known as pramindole, is a tricyclic antidepressant (TCA) used in Europe for the treatment of depression. It was introduced by Wyeth and has been used clinically since 1967. Notably, iprindole was the first second-generation antidepressant to be launched.Iprindole is unique compared to most other TCAs in that it is a relatively weak inhibitor of the reuptake of serotonin and norepinephrine and instead acts predominantly as an antagonist of 5-HT2 receptors, hence its classification as 'second-generation'. Additionally, side effects of iprindole are much less prominent relative to other TCAs and it is well tolerated. However, iprindole's efficacy may not be as great as other TCAs, especially in regards to anxiety relief.".